Aeon BiopharmaAEON
13F holders, Q3 2025 (September 30)21holders +3
5new positions
2sold out
$0.81avg. 13F price*
At the end of Q3 2025, 21 institutions reported holding Aeon Biopharma Inc. (AEON) in their 13F filings, up 3 from Q2 2025. 5 opened new positions and 2 sold out. The largest holders were Dauntless Investment Group, LLC ($910K), Vanguard Group Inc. ($80K) and Geode Capital Management, LLC ($38K).
- Company
- Aeon Biopharma Inc.
- CUSIP
- 00791X209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $115K |
| Exits | 2 | $34K |
All 13F filers, Q2 2025 → Q3 2025: 169,198 shares bought and 75,968 shares sold, net +93,230 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 21 holders
| Dauntless Investment Group, LLC | 2.39% | No change | 1,125,000 | $910K |
| Vanguard Group Inc. | 0.00% | New | 98,568 | $80K |
| Geode Capital Management, LLC | 0.00% | Add +127.5% | 47,073 | $38K |
| Blue Owl Capital Holdings LP | 0.01% | No change | 42,353 | $34K |
| StoneX Group Inc. | 0.00% | New | 17,578 | $14K |
| XTX Topco Ltd | 0.00% | New | 16,162 | $13K |
| Jane Street Group, LLC | 0.00% | New | 10,420 | $8K |
| BlackRock, Inc. | 0.00% | Reduce -0.7% | 2,834 | $2K |
| Bank of America Corp. | 0.00% | Reduce -0.4% | 2,376 | $2K |
| UBS Group AG | 0.00% | Reduce -96.2% | 1,192 | $964 |
| Dupont Capital Management Corp. | 0.00% | No change | 170 | $137 |
| Morgan Stanley | 0.00% | No change | 150 | $121 |
| SBI Securities Co., Ltd. | 0.00% | No change | 106 | $86 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 100 | $81 |
| GHP Investment Advisors, Inc. | 0.00% | Add +295.8% | 95 | $77 |
| Wells Fargo & Company | 0.00% | No change | 90 | $73 |
| Wolff Wiese Magana LLC | 0.00% | No change | 67 | $55 |
| MAI Capital Management | 0.00% | No change | 58 | $47 |
| CIBC Private Wealth Group LLC | 0.00% | No change | 33 | $27 |
| Barclays PLC | 0.00% | New | 21 | $17 |
| Danske Bank A/S | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is AEON's weight in each manager's 13F, not the share of Aeon Biopharma Inc. the manager owns.